ScholarWorks@Hanyang University: Roh, Sung won

Detailed Information

Roh, Sung won (노성원)

서울 의과대학 (DEPARTMENT OF PSYCHIATRY)

Research Area

Tel 02-2290-8422
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Suicide:6||Depression:5||Schizophrenia:4||schizophrenia:3||Nicotine:3||Smoking:3||Haloperidol:2||Cognitive function:2||CREB:2||NCAM140:2||Risperidone:2||Alcohol dependence:2||Safety:2||alcohol dependence:2||Addiction:2||family history:2||pCREB:2||Tobacco:2||bipolar disorder:2||Smoking cessation:2||Treatment outcome:2||Brainderived neurotrophic factor:2||Efficacy:2||ALDH2:2||Internet gaming disorder:2||machine learning:2||major depressive disorder:2||Depression Korea Culture Nonpharmacological treatment.:2||Rat:2||Bloodbased markers:1||Body Mass Index:1||Cardiovascular disease:1||Celebrity:1||Clinical highrisk:1||Cognitive performance:1||Community·Addiction·Community addiction management center:1||Compulsive buying:1||Corticostriatallimbic circuit:1||D:1||Death:1||Death certificate data:1||Dementia:1||Department of psychiatry:1||Depressive Mood:1||Depressive mood:1||Desvenlafaxine:1||Development:1||Dexamethasone:1||Diffusion tensor imaging:1||Disability types:1||Disulfiram:1||Driving ability:1||Driving impairment:1||ELISA:1||Education:1||Elderly:1||Factor analysis· Factor structure:1||First episode psychosis:1||Firstepisode schizophrenia:1||Fluoxetine:1||Functional connectivity:1||GABA:1||GABRA2:1||Generalized anxiety disorder:1||HSP:1||Healthy diet:1||Heat shock protein:1||Hopelessness:1||Improvement plan:1||Income:1||International comparison:1||Internet addiction:1||Internet use disorder:1||Keywords Alcoholism:1||Korea:1||Leadership, Ethics, medical, Professional role, Mental health:1||Living arrangement:1||Location of death:1||Lurasidone:1||MK801:1||MMPI:1||MRMMS:1||Machine learning:1||Major depressive disorder:1||Marital satisfaction:1||Marriage:1||Mecamylamine:1||Medical institutions:1||Mental Health:1||Mental health:1||Mental health R&:1||Mental health indicator:1||Mental health service:1||Mental health services:1||Metabolic syndrome:1||Multiple reaction monitoring:1||Nerve growth factor:1||Neurotrophin:1||Online gaming addiction:1||Online shopping addiction:1||Overdose:1||Paliperidone:1||Patients:1||Penn state worry questionnaire:1||People with disability:1||Phone interview:1||Physical activity:1||Plasma:1||Preschool:1||Psychiatric comorbidity:1||Psychiatric research, Research and Development (R&D), Activation:1||Psychological Distress:1||Psychological stress:1||Randomized Controlled Trial:1||Randomized clinical trial:1||Relapse:1||Repeated suicide attempts:1||Rheumatoid arthritis:1||Richmond Compulsive Buying Scale:1||Rumination:1||Schizophrenia · Haloperidol · Aripiprazole · Driving · Psychomotor performance:1||Sex:1||Sociodemographic factor:1||Socioeconomic position:1||Special hospital:1||Standards:1||State Anger:1||Subjective Response:1||Subjective memory complaints:1||Substance use:1||Suicidal Ideation:1||Suicidal ideation:1||Suicide prevention strategy:1||Suicide rate:1||Suicide risk:1||Survival analysis.:1||T1weighted magnetic resonance imaging:1||Trait Anger:1||Transforming Growth Factor beta1:1||Treatment adherence:1||Triglyceride:1||Ushaped Association:1||University hospital:1||Use:1||Validity:1||Validity study:1||Varenicline:1||Venlafaxine:1||Virtual reality therapy:1||Working memory:1||Worry:1||addictive shopping:1||adrenergic betaantagonists:1||alcohol:1||antidepressants:1||antipsychotics:1||anxiety:1||anxiety sensitivity:1||ascorbic acid:1||bipolar disorder (BD):1||brainderived neurotrophic factor:1||brooding:1||bupropion:1||cardiac complications:1||cardiomyopathy:1||cardiovascular diseases:1||chronic disease:1||clamp:1||clozapine:1||cognition:1||community analysis:1||compulsive buying:1||continuous performance test:1||depression:1||depressive disorder:1||discriminative model:1||dissociation:1||escitalopram:1||generalizable model:1||health screening:1||highrisk for mental illness:1||hippocampus:1||human error:1||impulsivity:1||intellectual structure:1||intention:1||international collaboration:1||keyword networks analysis:1||major depressive disorder (MDD):1||mental illness:1||mild cognitive impairment:1||mortality:1||multiple reaction monitoringmass spectrometry (MRMMS):1||nerve growth factor:1||neurobiology:1||neuroimaging:1||neurotrophic factor:1||neurotrophin:1||nicotine:1||nondepleted plasma:1||nutrition:1||online shopping:1||pharmacotherapy:1||planning:1||pluripotential:1||proteomics:1||psychiatry:1||quantitative targeted proteomics:1||randomized controlled trial:1||reflection:1||retrospective cohort study:1||risk:1||rumination:1||selfefficacy:1||selfharm:1||sleep quality:1||speed and accuracy:1||sustained attention:1||train drivers:1||transdiagnostic:1||trauma:1||typical drugs:1||vitamin A:1||vitamin E:1||working memory:1||강박구매:1||결혼:1||결혼 만족도:1||국제공동연구:1||대학병원:1||리더십, 윤리, 사회적 역사, 정신보건:1||리치몬드 강박구매 척도:1||발전방안:1||범불안장애:1||분노 경험:1||분노 억제:1||분노 조절/내부:1||분노 조절/외부:1||분노 표출:1||분노 표현:1||상태 분노:1||성:1||알코올사용장애:1||온라인 쇼핑중독:1||요인구조:1||요인분석:1||우울증 한국 문화 비약물학적 치료.:1||전문병원:1||정신건강의학 연구, 연구개발, 활성화:1||정신건강의학과:1||정신의학:1||조현병:1||조현병·할로페리돌·아리피프라졸·운전·정신운동수행:1||중독·치료지침서, 수용개작, 알코올사용장애, 알코올사용장애 치료:1||지역사회·중독·중독관리통합지원센터:1||지적구조:1||치료결과:1||치료순응도:1||커뮤니티 분석:1||키워드 네트워크 분석:1||타당도:1||타당화 연구:1||특성 분노:1||펜실베니아 걱정질문지:1||플루세틴:1||해마:1||AUDIT:1||Accident:1||Acetaldehyde:1||Addiction, Guidelines, Adaptation, Alcohol use disorder, Alcohol use disorder treatment:1||Age:1||Alcohol:1||Alcohol Clamping:1||Alcohol Dependence:1||Alcohol Use:1||Alcohol drinking:1||Alcohol intake:1||Alcohol use disorder:1||Alcohols:1||Amplitude lowfrequency fluctuation:1||Anger ControlIn:1||Anger ControlOut:1||Anger ExpressionIn:1||Anger ExpressionOut:1||Anger experience:1||Anger expression:1||Antidepressant:1||Anxiety sensitivity:1||Aripiprazole:1||Attention:1||Attenuated psychosis syndrome:1||Autism spectrum disorder:1||Binge use:1||Biomarker:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE